Cue Health(HLTHQ)
$0.000.00 (0.00%)
HLTHQ
Cue Health financials statements
$0.00
At close:0.00 (0.00%)
Want to see HLTHQ full AI Analyst Report?
Cue Health (HLTHQ) Ratios
224 Followers
Cue Health Ratios
HLTHQ's free cash flow for Q4 2023 was $-30.55M. For the 2023 fiscal year, HLTHQ's free cash flow was decreased by $-1.83M and operating cash flow was $-28.72M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.54 | 5.21 | 4.01 | 1.18 | 3.26 |
| Quick Ratio | 2.22 | 4.06 | 3.48 | 0.94 | 3.26 |
| Cash Ratio | 1.86 | 3.40 | 2.54 | 0.82 | 3.02 |
| Solvency Ratio | -3.54 | -1.18 | 0.30 | -0.17 | -1.43 |
| Operating Cash Flow Ratio | -3.17 | -1.58 | -0.06 | 0.59 | -2.76 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -0.97 | 17.03 | -5.13 |
| Net Current Asset Value | $ 20.83M | $ 253.07M | $ 436.71M | $ -57.71M | $ 3.71M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.08 | 0.06 | 0.06 | 0.26 |
| Debt-to-Equity Ratio | 0.19 | 0.10 | 0.08 | 0.26 | 0.47 |
| Debt-to-Capital Ratio | 0.16 | 0.09 | 0.08 | 0.21 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Financial Leverage Ratio | 1.36 | 1.20 | 1.33 | 4.22 | 1.76 |
| Debt Service Coverage Ratio | -272.67 | -214.78 | 6.85 | -6.80 | -6.19 |
| Interest Coverage Ratio | -340.68 | -315.71 | 19.39 | -120.66 | -136.63 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.32 | 0.38 | 0.47 | 0.14 | 0.05 |
| Net Debt to EBITDA | 0.11 | 1.26 | -2.18 | 2.73 | 0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | -97.89% | 31.75% | 55.26% | 34.86% | 100.00% |
| EBIT Margin | -572.24% | -42.02% | 20.87% | -202.01% | -308.69% |
| EBITDA Margin | -484.61% | -30.67% | 26.99% | -172.09% | -252.85% |
| Operating Profit Margin | -614.82% | -42.12% | 30.77% | -196.60% | -313.42% |
| Pretax Profit Margin | -574.05% | -42.15% | 19.28% | -206.30% | -310.99% |
| Net Profit Margin | -581.51% | -40.14% | 5.36% | -206.30% | -310.99% |
| Continuous Operations Profit Margin | -581.51% | -40.14% | 13.98% | -206.30% | -310.99% |
| Net Income Per EBT | 101.30% | 95.22% | 27.78% | 100.00% | 100.00% |
| EBT Per EBIT | 93.37% | 100.08% | 62.65% | 104.93% | 99.22% |
| Return on Assets (ROA) | -109.91% | -27.94% | 3.52% | -14.97% | -75.31% |
| Return on Equity (ROE) | -149.24% | -33.66% | 4.68% | -63.20% | -132.38% |
| Return on Capital Employed (ROCE) | -133.25% | -32.67% | 24.60% | -28.13% | -91.85% |
| Return on Invested Capital (ROIC) | -130.48% | -30.61% | 17.40% | -26.87% | -81.16% |
| Return on Tangible Assets | -116.66% | -28.63% | 3.55% | -15.07% | -75.31% |
| Earnings Yield | -1498.71% | -63.33% | 1.69% | -1.63% | -0.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 38.88 | 25.38 | 5.85 | 5.51 | 33.13 |
| Payables Turnover | 16.49 | 46.15 | 7.43 | 0.63 | 0.00 |
| Inventory Turnover | 9.05 | 4.01 | 3.13 | 0.41 | 0.00 |
| Fixed Asset Turnover | 0.43 | 1.76 | 2.41 | 0.21 | 0.57 |
| Asset Turnover | 0.19 | 0.70 | 0.66 | 0.07 | 0.24 |
| Working Capital Turnover Ratio | 0.35 | 1.20 | 2.33 | 1.19 | 0.00 |
| Cash Conversion Cycle | 27.58 | 97.41 | 129.96 | 383.53 | 11.02 |
| Days of Sales Outstanding | 9.39 | 14.38 | 62.41 | 66.28 | 11.02 |
| Days of Inventory Outstanding | 40.32 | 90.94 | 116.66 | 899.43 | 0.00 |
| Days of Payables Outstanding | 22.13 | 7.91 | 49.11 | 582.18 | 0.00 |
| Operating Cycle | 49.71 | 105.32 | 179.07 | 965.71 | 11.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.90 | -0.76 | -0.06 | 0.64 | -0.09 |
| Free Cash Flow Per Share | -1.03 | -1.19 | -0.85 | 0.10 | -0.11 |
| Dividend Paid and CapEx Coverage Ratio | -6.96 | -1.79 | -0.08 | 1.18 | -4.45 |
| Capital Expenditure Coverage Ratio | -6.96 | -1.79 | -0.08 | 1.18 | -4.45 |
| Operating Cash Flow Coverage Ratio | -2.87 | -2.05 | -0.16 | 4.67 | -1.81 |
| Operating Cash Flow to Sales Ratio | -2.15 | -0.23 | -0.02 | 4.03 | -1.98 |
| Free Cash Flow Yield | -632.49% | -57.29% | -6.38% | 0.49% | -0.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.07 | -1.58 | 59.30 | -61.51 | -141.34 |
| Price-to-Sales (P/S) Ratio | 0.39 | 0.63 | 3.18 | 126.89 | 439.55 |
| Price-to-Book (P/B) Ratio | 0.10 | 0.53 | 2.78 | 38.87 | 187.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.16 | -1.75 | -15.69 | 202.34 | -181.49 |
| Price-to-Operating Cash Flow Ratio | -0.18 | -2.72 | -207.77 | 31.47 | -222.28 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.00 | -0.35 | -0.45 | 0.00 |
| Enterprise Value Multiple | 0.03 | -0.80 | 9.59 | -71.01 | -173.42 |
| Enterprise Value | -8.03M | 119.08M | 1.60B | 2.80B | 2.91B |
| EV to EBITDA | 0.03 | -0.80 | 9.59 | -71.01 | -173.42 |
| EV to Sales | -0.13 | 0.25 | 2.59 | 122.19 | 438.48 |
| EV to Free Cash Flow | 0.05 | -0.68 | -12.78 | 194.85 | -181.04 |
| EV to Operating Cash Flow | 0.06 | -1.06 | -169.23 | 30.31 | -221.74 |
| Tangible Book Value Per Share | 1.51 | 3.78 | 4.78 | 0.50 | 0.11 |
| Shareholders’ Equity Per Share | 1.64 | 3.89 | 4.83 | 0.51 | 0.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.05 | 0.27 | 0.00 | 0.00 |
| Revenue Per Share | 0.42 | 3.27 | 4.22 | 0.16 | 0.05 |
| Net Income Per Share | -2.44 | -1.31 | 0.23 | -0.33 | -0.14 |
| Tax Burden | 1.01 | 0.95 | 0.28 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.92 | 1.02 | 1.01 |
| Research & Development to Revenue | 2.35 | 0.35 | 0.07 | 1.24 | 3.23 |
| SG&A to Revenue | 0.89 | 0.20 | 0.13 | 1.04 | 0.00 |
| Stock-Based Compensation to Revenue | 0.76 | 0.13 | 0.07 | 0.14 | 0.00 |
| Income Quality | 0.37 | 0.58 | -0.11 | -1.95 | 0.64 |
Currency in USD
